BioCryst Pharmaceuticals
BCRX
#4777
Rank
โ‚ฌ1.50 B
Marketcap
7,25ย โ‚ฌ
Share price
1.47%
Change (1 day)
43.77%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.91 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚ฌ0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.87 B11.73%
2022-12-31โ‚ฌ0.78 B28.28%
2021-12-31โ‚ฌ0.61 B113.28%
2020-12-31โ‚ฌ0.28 B135.27%
2019-12-31โ‚ฌ0.12 B43.37%
2018-12-31โ‚ฌ85.32 M8.34%
2017-12-31โ‚ฌ78.75 M-6.15%
2016-12-31โ‚ฌ83.91 M22.94%
2015-12-31โ‚ฌ68.25 M35.56%
2014-12-31โ‚ฌ50.35 M39.1%
2013-12-31โ‚ฌ36.19 M-17.29%
2012-12-31โ‚ฌ43.76 M-15.67%
2011-12-31โ‚ฌ51.9 M57.1%
2010-12-31โ‚ฌ33.03 M-15.36%
2009-12-31โ‚ฌ39.03 M42.61%
2008-12-31โ‚ฌ27.37 M-48.64%
2007-12-31โ‚ฌ53.29 M48.57%
2006-12-31โ‚ฌ35.86 M4.13%
2005-12-31โ‚ฌ34.44 M1390.89%
2004-12-31โ‚ฌ2.31 M76.48%
2003-12-31โ‚ฌ1.3 M16.78%
2002-12-31โ‚ฌ1.12 M-56.62%
2001-12-31โ‚ฌ2.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.83 B-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.26 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.29 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.14 B 134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ33.74 B 3,586.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.54 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.92 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.07 B 17.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.87 M-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA